|
GLS expression profile based on
|
LAML : Acute Myeloid Leukemia Note
FAB classification information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| M0-vs-M1 |
1.60831999999056E-05 |
| M0-vs-M2 |
8.388800E-04 |
| M0-vs-M3 |
4.09440000015415E-07 |
| M0-vs-M4 |
2.90160000471218E-08 |
| M0-vs-M5 |
4.87219997680199E-09 |
| M0-vs-M6 |
4.884300E-02 |
| M0-vs-M7 |
6.264200E-02 |
| M1-vs-M2 |
2.592200E-01 |
| M1-vs-M3 |
4.297400E-03 |
| M1-vs-M4 |
1.621910E-02 |
| M1-vs-M5 |
1.23779986260786E-10 |
| M1-vs-M6 |
5.897200E-01 |
| M1-vs-M7 |
8.980800E-01 |
| M2-vs-M3 |
5.83730000000005E-05 |
| M2-vs-M4 |
1.416170E-03 |
| M2-vs-M5 |
2.93289836861277E-11 |
| M2-vs-M6 |
4.263400E-01 |
| M2-vs-M7 |
7.719800E-01 |
| M3-vs-M4 |
3.869400E-01 |
| M3-vs-M5 |
9.160500E-04 |
| M3-vs-M6 |
4.162200E-01 |
| M3-vs-M7 |
3.512000E-02 |
| M4-vs-M5 |
2.43009999999488E-05 |
| M4-vs-M6 |
8.152800E-01 |
| M4-vs-M7 |
2.843000E-01 |
| M5-vs-M6 |
1.292130E-02 |
| M5-vs-M7 |
7.69080000000422E-05 |
| M6-vs-M7 |
4.523200E-01 |
|
|
LAML : Acute Myeloid Leukemia Note
Patient race information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Caucasian-vs-AfricanAmerican |
8.906200E-01 |
| Caucasian-vs-Asian |
1.437970E-01 |
| AfricanAmerican-vs-Asian |
1.514000E-01 |
|
|
LAML : Acute Myeloid Leukemia
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Male-vs-Female |
7.551400E-01 |
|
|
LAML : Acute Myeloid Leukemia Note
Patient age information is not available for 1 sample.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.335960E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.022600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.039700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.486400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.662370E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.091010E-01 |
|
|
LAML : Acute Myeloid Leukemia Note
FLT3 mutation status is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| With-FLT3-mutation-vs-Without-FLT3-mutation |
9.524800E-01 |
|
|
LAML : Acute Myeloid Leukemia Note
PML/RAR-fusion status is not available for 161 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| With-PML/RAR-fusion-vs-Without-PML/RAR-fusion |
2.083800E-01 |
|
|
LAML : Acute Myeloid Leukemia Note
RAS activation status is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| With-RAS-activation-vs-Without-RAS-activation |
4.346600E-01 |
|
|
|
GLS expression profile based on
|
LAML : Acute Myeloid Leukemia Note
FAB classification information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| M0-vs-M1 |
1.60831999999056E-05 |
| M0-vs-M2 |
8.388800E-04 |
| M0-vs-M3 |
4.09440000015415E-07 |
| M0-vs-M4 |
2.90160000471218E-08 |
| M0-vs-M5 |
4.87219997680199E-09 |
| M0-vs-M6 |
4.884300E-02 |
| M0-vs-M7 |
6.264200E-02 |
| M1-vs-M2 |
2.592200E-01 |
| M1-vs-M3 |
4.297400E-03 |
| M1-vs-M4 |
1.621910E-02 |
| M1-vs-M5 |
1.23779986260786E-10 |
| M1-vs-M6 |
5.897200E-01 |
| M1-vs-M7 |
8.980800E-01 |
| M2-vs-M3 |
5.83730000000005E-05 |
| M2-vs-M4 |
1.416170E-03 |
| M2-vs-M5 |
2.93289836861277E-11 |
| M2-vs-M6 |
4.263400E-01 |
| M2-vs-M7 |
7.719800E-01 |
| M3-vs-M4 |
3.869400E-01 |
| M3-vs-M5 |
9.160500E-04 |
| M3-vs-M6 |
4.162200E-01 |
| M3-vs-M7 |
3.512000E-02 |
| M4-vs-M5 |
2.43009999999488E-05 |
| M4-vs-M6 |
8.152800E-01 |
| M4-vs-M7 |
2.843000E-01 |
| M5-vs-M6 |
1.292130E-02 |
| M5-vs-M7 |
7.69080000000422E-05 |
| M6-vs-M7 |
4.523200E-01 |
|
|
LAML : Acute Myeloid Leukemia Note
Patient race information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Caucasian-vs-AfricanAmerican |
8.906200E-01 |
| Caucasian-vs-Asian |
1.437970E-01 |
| AfricanAmerican-vs-Asian |
1.514000E-01 |
|
|
LAML : Acute Myeloid Leukemia
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Male-vs-Female |
7.551400E-01 |
|
|
LAML : Acute Myeloid Leukemia Note
Patient age information is not available for 1 sample.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.335960E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.022600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.039700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.486400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.662370E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.091010E-01 |
|
|
LAML : Acute Myeloid Leukemia Note
FLT3 mutation status is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| With-FLT3-mutation-vs-Without-FLT3-mutation |
9.524800E-01 |
|
|
LAML : Acute Myeloid Leukemia Note
PML/RAR-fusion status is not available for 161 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| With-PML/RAR-fusion-vs-Without-PML/RAR-fusion |
2.083800E-01 |
|
|
LAML : Acute Myeloid Leukemia Note
RAS activation status is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| With-RAS-activation-vs-Without-RAS-activation |
4.346600E-01 |
|
|
